Cambridge Investment Research Advisors, Inc.
Position in EW — Edwards Lifesciences Corp
CIK 1419186
FAIRFIELD, IA
Position in EW
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$2,276,033
-$470,722 QoQ
Shares Held
28,422
-11.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Common Shares in EW Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Cambridge Investment Research Advisors, Inc. holds $100,026,792 across 24 Medical Devices names. EW ranks #8 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
302,423 | $31,049,769 | |
| 2 | SYK |
Stryker Corp
|
77,649 | $25,514,684 | |
| 3 | MDT |
Medtronic plc
|
224,017 | $19,411,073 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
85,273 | $6,069,732 | |
| 5 | BSX |
Boston Scientific Corp
|
53,823 | $3,377,393 | |
| 6 | DXCM |
Dexcom Inc
|
50,294 | $3,158,463 | |
| 7 | STE |
STERIS plc
|
10,820 | $2,392,626 | |
| 8 | EW |
Edwards Lifesciences Corp
This page
|
28,422 | $2,276,033 |
All Filings in EW
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,276,033 | 28,422 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,746,755 | 32,220 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,063,238 | 26,530 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,226,247 | 28,465 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,062,708 | 28,459 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $2,505,249 | 33,841 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,399,000 | 36,354 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $2,687,967 | 29,100 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $3,269,776 | 34,217 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $2,609,503 | 34,223 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,729,077 | 39,392 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $3,620,479 | 38,381 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $3,294,556 | 39,823 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,975,969 | 39,887 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,408,074 | 41,245 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $4,046,364 | 42,553 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $5,240,894 | 44,520 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $6,146,888 | 47,448 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $5,422,079 | 47,894 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $5,849,737 | 56,481 | Shares | Sole | 2021-08-10 | |
| 2020-12-31 | $5,766,009 | 63,203 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $6,029,443 | 75,538 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $4,913,099 | 71,091 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $1,259,855 | 20,038 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||